Research Focus

Radiation Oncology; Associate Attending

Recent additions – View all

1. Androgen suppression with abiraterone acetate, leuprolide, PARP inhibition, and stereotactic body radiotherapy (ASCLEPIuS) in high-risk and node positive prostate cancer (PCa): Phase I multicenter results

   Meeting Abstract

   Jackson, W. C.; Dess, R. T.; Jia, A. Y.; Nagar, H.; Desai, N. B.; Hannan, R.; Hearn, J. W. D.; Reichert, Z. R.; Marciscano, A. E.; Davis, B.; more...
   Journal of Clinical Oncology (2025)

   Fulltext@MSK | Save
2. National cancer system characteristics and prostate cancer outcomes: A global analysis

   Meeting Abstract

   Dee, E. C. C.; Iyengar, R.; Narayan, A.; Feliciano, E. J. G.; Nagar, H.; Mahal, B. A.; Nguyen, P. L.
   Journal of Clinical Oncology (2025)

   Fulltext@MSK | Save
3. Clinical outcomes for radiographic node-positive prostate cancer following definitive radiotherapy

   Meeting Abstract

   Dodge, J.; Boe, L. A.; Boehm, K.; Guttmann, D.; Moore, Z.; Parikh, D.; Barsky, A.; Kollmeier, M.; McBride, S. M.; Brennan, V.; more...
   Journal of Clinical Oncology (2025)

   Fulltext@MSK | Save